Advancing intraoperative tumour detection and molecular-guided precision surgery, FDA's approval of pafolacianine injection: an editorial
- PMID: 38222777
- PMCID: PMC10783271
- DOI: 10.1097/MS9.0000000000001534
Advancing intraoperative tumour detection and molecular-guided precision surgery, FDA's approval of pafolacianine injection: an editorial
Conflict of interest statement
There are no conflicts of interest.Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article
References
-
- Mahalingam SM, Kularatne SA, Myers CH, et al. Evaluation of novel tumor-targeted near-infrared probe for fluorescence-guided surgery of cancer. J Med Chem 2018;61:9637–9646. - PubMed
-
- Cision, PR Newswire On Target Laboratories, Inc. On Target Laboratories announces FDA approval of CYTALUXTM (pafolacianine) injection for identification of ovarian cancer during surgery, 2021. https://www.prnewswire.com/news-releases/on-target-laboratories-announce...
Publication types
LinkOut - more resources
Full Text Sources